Bing

SEARCH HISTORY

Harvard Bioscience (NASDAQ:HBIO) Director David Green sold 17,103 shares of Harvard Bioscience stock in a transaction dated Friday, July 17th. The stock was sold at an average price of $5.26, for a total value of $89 …
wkrb13.com · 7/20/2015
Harvard Bioscience (NASDAQ:HBIO) traded down 1.81% on Thursday, hitting $4.88. The stock had a trading volume of 136,035 shares. The firm has a market capitalization of $163.25 million and a price-to-earnings ratio of 697.14. The stock’s 50-day …
Ticker Report · 2 hours ago
Harvard Bioscience
Harvard Bioscience (NASDAQ:HBIO) Director David Green sold 17,103 shares of Harvard Bioscience stock in a transaction dated Friday, July 17th. The stock was sold at an average price of $5.26, for a total value of $89 …
Mideast Times · 7/21/2015
More from Bing News
A year ago, they were trading at $4.71. This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on HBIO at http://www.zacks.com/ap/HBIO
CNBC · 10 hours ago
Harvard Bioscience
The below chart shows the historical "days to cover" for HBIO at previous short interest release dates: START SLIDESHOW: Top 25 S.A.F.E. Dividend Stocks » An increased "days to cover" value could indicate that …
The Street · 1 day ago
Harvard Bioscience (NASDAQ:HBIO) Director David Green sold 17,103 shares of the company’s stock in a transaction that occurred on Friday, July 17th. The stock was sold at an average price of $5.26, for a total transaction of $89,961.78. Following the ...
sleekmoney.com · 7/19/2015
Financial Guidance Harvard Bioscience, or the Company ... severance and restructuring expenses and stock-based compensation expense. They also exclude the tax impact of the reconciling items. This non-GAAP financial information approximates …
Financial Content · 10 hours ago
GAAP
1. Includes (a) a deferred stock award of 29,215 restricted stock units which vest on January 1, 2016; (b) a deferred stock award of 27,375 restricted stock units which vest in equal installments on January 1, 2016 and January 1, 2017; (c) a deferred stock ...
StreetInsider · 7/18/2015
One such stock that you may want to consider dropping is Harvard Bioscience Inc. (HBIO), which has witnessed a significant price decline in the past four weeks, and it has seen negative earnings estimate revisions for the current quarter and the current year.
Yahoo Finance · 5/27/2015
One such stock that you may want to consider dropping is Harvard Bioscience Inc. (HBIO - Snapshot Report), which has witnessed a significant price decline in the past four weeks, and it has seen negative earnings estimate revisions for the current quarter ...
ZACKS · 5/27/2015